Archive for the ‘Aethlon Medical Inc’ Category

Aethlon Medical Inc.

August 19th, 2015 | Posted in 2015, Aethlon Medical Inc

Aethlon Medical Inc., San Diego, has been approved to join the Nasdaq Stock Market. Aethlon is the creator of affinity biofiltration devices to treat life-threatening diseases.

Aethlon Medical

June 2nd, 2015 | Posted in 2015, Aethlon Medical Inc

Aethlon Medical, San Diego, has received approval from the Medical Devices Bureau of Health Canada for a clinical study protocol to treat Ebola patients with its Hemopurifier. The Hemopurifier is a first-in-class affinity biofiltration device designed for the broad-spectrum elimination of viral pathogens from the circulatory system of infected individuals.

Aethlon Medical Inc

October 16th, 2014 | Posted in 2014, Aethlon Medical Inc

Aethlon Medical Inc, San Diego, was informed that DARPA (Defense Advanced Research Projects Agency) will exercise an option to proceed with year four of a five-years $5.9 Million contract. Aethlon develops targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions.

Aethlon Medical Inc

October 5th, 2011 | Posted in 2011, Aethlon Medical Inc

Aethlon Medical Inc. – Is a developer of therapeutic filtration devices, has been awarded a $6.8-million contract from the Defense Advanced Research Project Agency to develop a device to reduce the incidence of sepsis, a fatal bloodstream infection that is often the cause of death in combat-injured soldiers.

Aethlon Medical Inc

March 9th, 2011 | Posted in 2011, Aethlon Medical Inc

Aethlon Medical Inc – is a developer of therapeutic filtration devices to address infectious disease and cancer. Aethlon announced that the US Food and Drug Administration “FDA” has granted Aethlon’s request to export its “Hemopurifier” medical device to India.